Over the past year, news reports have brought attention to cancer risks that are increased by power morcellation with hysterectomy procedures. But gaining less attention is the risk that the procedure may spread other benign, but still life-disrupting, uterine diseases. Earlier this year, Obstetrics &... Read More

Following a harrowing and emotional trial before a Glasgow, Kentucky jury, ten out of 12 jurors agreed that T.J. Samson Community Hospital engaged in negligent conduct with regard to one of its patients during the birth of her son, who now suffers from a debilitating... Read More

On November 25, Bloomberg News reported that HCA Holdings, which is one of the country’s largest hospital networks with 280 hospitals and clinics both here and England, will halt the use of power morcellators in hysterectomy or fibroid tumor removals. The power morcellation ban came... Read More

On November 17, 2014, the U.S. Judicial Panel on Multidistrict Litigation (JPML) published its regular report, including data regarding the Granuflo dialysis lawsuits consolidated before U.S. District Judge Douglas P. Woodlock. According to the report, there are now 2,221 cases filed against Granuflo manufacturer Fresenius... Read More

Federal jurors in Charleston, West Virginia delivered another landmark transvaginal mesh trial verdict on November 20 – marking Boston Scientific’s second trial loss in just a few weeks. The vaginal mesh manufacturer was ordered to pay $18.5 million in compensation to four women who claimed they... Read More

On November 24, the U.S. Food and Drug Administration issued a statement that “boxed warning” labels would be added to laparoscopic power morcellators ─ a device used to grind up uterine fibroid growths. This hysterectomy morcellation warning follows a July FDA recommendation stating it isn’t... Read More

A federal judge has ordered Bayer Pharmaceuticals to produce sales call notes pertinent to a Mirena lawsuit currently underway in California. The judge determined that provision of these sales call notes could support allegations by the plaintiff that the company promoted their product while minimizing... Read More

A recent study has revealed that a new type of cholesterol-lowering drug can protect patients from heart attacks and strokes, without the risks associated with statins. One of the most popular statins, Lipitor, has been prescribed to more than 29 million people. Patients have cited... Read More